Back

SINGLE-AF: Anticoagulation for atrial fibrillation with intermediate stroke risk

28 August 2026 (11:15 - 11:25)
Organised by: Logo
Congress Presentation Part of: HOT LINE 1 Oral Anticoagulation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Boyoung Joung

Yonsei University, Seoul (Korea (Republic of))

14 More presentations in this session

Presentation thumbnail
CARDIO-TTRansform: efficacy and safety of eplontersen in patients with transthyretin amyloid cardiomyopathy
Doctor M. Maurer (New York, US)
Slides Video
Presentation thumbnail
Discussant review - CARDIO-TTRansform
Professor G. Sinagra (Trieste, IT)
Slides Video
Presentation thumbnail
Panel discussion - CARDIO-TTRansform
Presentation thumbnail
Discussant review - SINGLE-AF
Professor I. Van Gelder (Groningen, NL)
Slides Video
Presentation thumbnail
Panel discussion - SINGLE-AF

Access the full session

Session thumbnail
HOT LINE 1
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Session
Ask the Trialists - SINGLE-AF
28 August 2026
thumbnail
Congress Presentation
ALONE-AF: Discontinuing long-Term oral anticoagulation after successful atrial fibrillation ablation
31 August 2025
thumbnail
Congress Presentation
Effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes with oral anticoagulation therapy in patients with device-detected atrial fibrillation. The NOAH-AFNET 6 trial.
9 April 2024
thumbnail
Congress Session
HOT LINE 5
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources